This is literally the same mechanism that GLP-1 medications are activating just from the other direction
9,10 The cGSTs are divided into seven subtypes according to similarities in amino-acid sequence, different structure of genes, and immunological cross-reactivity
The FDA requires GLP-1 receptor agonists to carry a black-box warning regarding the risk of thyroid C-cell tumors, and it recommends against using them in patients with a personal or family history of medullary thyroid cell cancer or multiple endocrine neoplasia syndrome type 2a or 2b
Every patient at our Doral clinic can name the provider on their case, see the providers credentials, and find the NPI number in the public CMS registry
Caspersen, I
Your vial label states the concentration clearly, usually formatted as "5mg/500mcg/1mL" for the semaglutide/B12 combination, indicating 5 mg semaglutide and 500 mcg B12 per milliliter